Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251
Youki Ueda(Okayama University), Nobuyuki Kato(Nippon Institute of Technology), Takayuki Hishiki(National Institute of Infectious Diseases), Hironori Nishitsuji(Fujita Health University), Nobuaki Okumura(Bee Research Institute), GU Wei-lin(Okayama University), Michiaki Masuda(Dokkyo Medical University), Shinya Satoh(Korea Advanced Institute of Science and Technology), Kunitada Shimotohno(National Center for Global Health and Medicine), Tomohiro Ishikawa(Dokkyo Medical University), Hye‐Sook Kim(Okayama University), Koji Ishii(National Institute of Infectious Diseases), Masanori Ikeda(Okayama University Hospital), Fumihiro Kato(National Institute of Infectious Diseases), Sayaka Yoshizaki(National Institute of Infectious Diseases), Hiromichi Dansako(Okayama University)
Cited by 7
Related Papers
The lipid droplet is an important organelle for hepatitis C virus production
|Nature Cell Biology|2007|1.2k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125
|Proceedings of the National Academy of Sciences|2007|474
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
|Hepatology|2006|311
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
|Proceedings of the National Academy of Sciences|2019|241